DrugPatentWatch Database Preview
Profile for Canada Patent: 2602042
US Patent Family Members and Approved Drugs for Canada Patent: 2602042
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Sep 18, 2027 | Bayer Hlthcare | FINACEA | azelaic acid |
➤ Try a Free Trial | Oct 24, 2023 | Bayer Hlthcare | FINACEA | azelaic acid |
➤ Try a Free Trial | Oct 24, 2023 | Bayer Hlthcare | FINACEA | azelaic acid |
➤ Try a Free Trial | Mar 1, 2024 | Bayer Hlthcare | FINACEA | azelaic acid |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |